- Grinta’s Acquisition of Citi Clinic Grants It Access to Over 150,000 Patients and Strengthens Its Presence in the Healthcare Sector.
- The company has received a strategic investment from Beltone and Raed Ventures to support its expansion and enhance its services in the market.
- Grinta is working on strengthening its presence in Tanzania through exports, partnerships, and the launch of a new pharmacy chain.
Grinta, a healthcare and pharmaceutical solutions company, has announced its acquisition of Citi Clinic, a well-established primary healthcare service chain in Egypt. Alongside this move, Grinta secured an undisclosed amount of strategic investment through a funding round led by Beltone Venture Capital and Raed Ventures, marking a key step in its expansion.
The acquisition of Citi Clinic gives Grinta access to over 150,000 patients, strengthening its presence in the healthcare sector and reinforcing its commitment to accessible and high-quality care.
Mohamed Azab, Co-founder and CEO of Grinta, shared his perspective:
“The acquisition of Citi Clinic is a transformative step for Grinta. It not only allows us to enter the care market but also enables us to integrate offline and online services, reshaping how healthcare is accessed and delivered. We look forward to the opportunities ahead as we expand our reach and impact.”
This move aligns with a global shift where B2B pharmaceutical distributors are expanding into B2C operations. Companies such as McKesson and Walgreens have successfully adopted similar models, using their supply chain expertise to offer comprehensive healthcare services directly to consumers. Grinta aims to follow this approach by expanding both its physical and digital healthcare services across Egypt and East Africa.
As part of this transition, Grinta has exited its B2B retail pharmaceutical distribution business in Egypt to focus entirely on the care sector.
Ali Mokhtar, Managing Director of Beltone Venture Capital, commented:
“We are excited to support Grinta as they reshape the healthcare and pharmaceutical space. Their shift into primary care and retail reflects their ability to adapt to market demands, positioning them for long-term success in the region.”
Wael Nafee, General Partner at Raed Ventures, expressed confidence in Grinta’s strategy:
“We’re pleased to back Grinta and its management team once again. Their innovative approach continues to impress us, and with this acquisition, we’re looking forward to their ambitious plans to improve healthcare access and delivery across emerging markets.”
Beyond Egypt, Grinta is also expanding in East Africa, particularly in Tanzania, by exporting pharmaceutical products and forming partnerships with Egyptian manufacturers. Additionally, the company is developing a pharmacy chain in Tanzania through a buy-and-build strategy, further solidifying its presence in the region.
Grinta’s entry into the primary care market and focus on patient-centric solutions reflect its mission to transform healthcare across multiple regions, ensuring better access and quality for all.
